News Releases | Lucira Health, Inc

Year

04 May '22

Lucira Health to Participate in Bank of America 2022 Healthcare Conference

EMERYVILLE, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will participate in

28 Apr '22

Lucira Health to Announce First Quarter 2022 Financial Results

EMERYVILLE, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will report first

21 Apr '22

Lucira Health and USA Boxing Announce Exclusive Partnership for the 2022 Season

Lucira is the official COVID-19 test provider of USA Boxing athletes and staff and will commit $5 of support to the organization for each test purchased by fans Emeryville, Calif., April 21, 2022 -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company

11 Apr '22

Lucira Health Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

EMERYVILLE, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that on April 6, 2022, the Board of Directors of

31 Mar '22

Lucira Donates Rapid Molecular At-Home COVID-19 Test Kits to Protect the Safety of Tonga Red Cross Society Workers

COVID-19 Comes to Isolated Pacific Island of Tonga And Cases Soar After Volcanic Eruption and Tsunami EMERYVILLE, Calif., (March 31, 2022) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of

29 Mar '22

Lucira Health's COVID-19 & Flu At-Home Molecular Test Shows Positive Clinical Study Results

COVID-19 and Influenza (flu) have similar symptoms, as well as effective but distinct treatments, making tests to differentiate between these infections crucial The Lucira COVID-19 & Flu test is a single at-home molecular test designed to independently diagnose COVID-19, Flu A and Flu B in less

24 Mar '22

Lucira Health’s PCR-Quality At-Home COVID-19 Test Now Available Direct to Consumers in Canada

Lucira’s molecular test provides PCR-quality results in 30 minutes in a simple single-use test Lucira was the first at-home COVID-19 test authorized in Canada and has been used in public health programs and for safe travel EMERYVILLE, CA, March 24, 2022 (GLOBE NEWSWIRE) — Lucira Health, Inc.

10 Mar '22

Lucira Health Announces Fourth Quarter and Full Year 2021 Results and Reaffirms 2022 Financial Outlook

EMERYVILLE, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) (“Lucira Health,” “Lucira” or the “Company”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today reported

28 Feb '22

Lucira Health to Announce Fourth Quarter 2021 Financial Results

EMERYVILLE, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will

08 Feb '22

Lucira Health Secures Debt Facility of Up to $80 Million from Hercules Capital and Silicon Valley Bank

EMERYVILLE, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that on February 4,

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Next page
Last page

Displaying 11 - 20 of 23